DR. LEANN MICHELLE BLANKENSHIP M.D. NPI 1659634772

NPI Information

  • NPI: 1659634772
  • Provider Name: DR. LEANN MICHELLE BLANKENSHIP, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 400 TAYLOR BLVD STE 201
    PLEASANT HILL, CA
    ZIP 94523
  • Phone: (925) 687-2570

Map and Directions

Get Directions

NPI Details

DR. Leann Michelle Blankenship, M.D. is a hematology and oncology internal medicine in Pleasant Hill, CA with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Leann Michelle Blankenship, M.D. NPI is 1659634772. The provider is registered as an individual entity type and is a multiple single specialty group.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

400 TAYLOR BLVD STE 201
PLEASANT HILL, CA
ZIP 94523-163
Phone: (925) 687-2570
Fax: (925) 687-2847

The NPI 1659634772 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Uric acid level, blood (HCPCS:84550)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Injection of drug or substance into vein (HCPCS:96374)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Advance care planning, first 30 minutes (HCPCS:99497)
  • Folic acid level, serum (HCPCS:82746)
  • Extended office or other outpatient service, first hour (HCPCS:99354)

The enumeration date for this NPI number is 6/22/2012 and was last updated on 12/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology4301107781MICHIGANYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.